UK markets closed
NIKKEI 225
27,772.93 +305.70 (+1.11%) HANG SENG
24,952.35 +824.50 (+3.42%) CRUDE OIL
86.29 -0.67 (-0.77%) GOLD FUTURES
1,839.30 -3.90 (-0.21%) DOW
34,923.91 -104.74 (-0.30%) BTC-GBP
31,405.86 +594.50 (+1.93%)
BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:42PM EST. Market open.
| Previous close | 161.66 |
| Open | 166.41 |
| Bid | 158.15 x 900 |
| Ask | 158.40 x 800 |
| Day's range | 157.50 - 166.79 |
| 52-week range | 90.29 - 464.00 |
| Volume | |
| Avg. volume | 3,400,488 |
| Market cap | 38.281B |
| Beta (5Y monthly) | -1.38 |
| PE ratio (TTM) | 4.99 |
| EPS (TTM) | 31.62 |
| Earnings date | 30 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 319.41 |
- Editor's pickYahoo Finance
Why you should get a booster even though you could still get Omicron: Scientist
Though COVID-19 vaccines and boosters provide strong protection against severe disease, hospitalizations, and deaths, the quickly-spreading Omicron variant remains a significant challenge.
- Editor's pickYahoo Finance Video
COVID-19: 'Vaccination is the way' to keep the economy open, doctor says
Dr. Taison Bell, Assistant Professor of Medicine at the University of Virginia, joins Yahoo Finance Live to discuss Virginia getting rid of its mask mandate for schools, the Omicron variant, and coronavirus vaccinations.
- Zacks
ChemoCentryx (CCXI) Tavneos Gets EU Nod for ANCA Vasculitis
Following approval in the EU, ChemoCentryx (CCXI) plans to launch Tavneos for treating ANCA-associated vasculitis in first-half 2022.
© 2022 Yahoo. All rights reserved.
